A BILL 
To require direct-to-consumer advertisements for prescription 
drugs and biological products to include truthful and 
not misleading pricing information. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Plain Prescription 
4
Prices Act’’. 
5
19:47 Apr 15, 2022
H7529
2 
•HR 7529 IH
SEC. 2. REGULATING ADVERTISEMENTS FOR PRESCRIP-
1
TION 
DRUG 
AND 
BIOLOGICAL 
PRODUCT 
2
PRICES. 
3
(a) IN GENERAL.—Not later than one year after the 
4
date of the enactment of this Act, the Secretary of Health 
5
and Human Services, acting through the Administrator of 
6
the Centers for Medicare & Medicaid Services (referred to 
7
in this section as the ‘‘Administrator’’), shall promulgate 
8
regulations requiring each direct-to-consumer advertise-
9
ment on television (including broadcast, cable, streaming, 
10
and satellite television) for a prescription drug or biologi-
11
cal product for which payment is available under title 
12
XVIII or XIX of the Social Security Act to include a tex-
13
tual statement, which shall be truthful and not misleading, 
14
indicating the list price, as determined on the first day 
15
of the quarter during which the advertisement is being 
16
aired or otherwise broadcast, for a typical 30-day regimen 
17
or typical course of treatment (whichever is most appro-
18
priate). 
19
(b) DETERMINATIONS.—In promulgating regulations 
20
under subsection (a), the Administrator shall determine— 
21
(1) whether such regulations should apply with 
22
respect to additional forms of advertising; 
23
(2) the manner and format of textual state-
24
ments described in such subsection; 
25
(3) appropriate enforcement mechanisms; and 
26
19:47 Apr 15, 2022
H7529
3 
•HR 7529 IH
(4) whether such textual statements should in-
1
clude any other price information, as appropriate. 
2
Æ 
19:47 Apr 15, 2022
H7529
